Patheon has selected locations in Research Triangle Park (RTP) and Durham, NC for its global headquarters and new analytical development laboratory facilities.
Said Wes Wheeler, chief executive officer and president of Patheon Inc., "Patheon has over 300 US based customers and derives approximately 50% of its revenues from U.S.-based companies. This move positions us to attract top talent from the industry and represents another step towards our vision of becoming best provider of manufacturing and development services to the pharmaceutical industry."
The analytical development facility will be built to support its current U.S.-based pharmaceutical development operations in Cincinnati and will initially offer stability studies, validation testing and analytical chemistry services. The company has already selected the location of the new site in Research Triangle Park and will be ready for operation in the next three months.
According to a company statement, there will be no impact to Patheon's significant regional presence in Ontario, Canada, where the company operates four facilities with more than 1,500 employees.
"We are very pleased that Patheon has chosen North Carolina for its global headquarters and new laboratory facility," said NC Commerce Secretary Jim Fain. "This exciting announcement demonstrates clearly the leadership role North Carolina has developed in the life sciences sector as well as our strong and ongoing economic relationship with our Canadian neighbors."